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Abstract
Severe hyperbilirubinemia, which may result in kernicterus, is seen more frequently in
low and middle-income countries, such as Indonesia, than in high-income countries. In Indo-
nesia midwives, general practitioners (GPs), and pediatricians are involved in the care of
jaundiced newborn infants. It is unknown whether the high incidence of severe hyperbilirubi-
nemia in this country is related to a lack of awareness of existing hyperbilirubinemia guide-
lines issued by, for example, the World Health Organization, the American Academy of
Pediatrics, or the Indonesian Health Ministry, or to a lack of adherence to such guidelines.
The aim of this questionnaire study was to assess health professionals’ awareness of exist-
ing guidelines and their adherence to these guidelines in daily practice. We handed out a
ten-question questionnaire to midwives, GPs, and pediatricians that included questions
about the professionals themselves as well as clinical questions. The midwives completed
291 questionnaires, the GPs 206, and the pediatricians 154, all of which we used for our
analysis. Almost 30% of the midwives and 23% of the GPs were either unaware of any exist-
ing guidelines or they did not adhere to them. Only 54% of the midwives recognized the
warning signs of severe hyperbilirubinemia correctly, compared to 68% of the GPs and 89%
of the pediatricians. Twenty-eight percent of the midwives and 31% of the GPs indicated
that their first follow-up visit was after 72 hours, while 90% of them discharged infants after
less than 48 hours after birth. The awareness of and adherence to guidelines for preventing
and treating hyperbilirubinemia is low amongst the midwives and GPs in Indonesia. This
may be an important contributing factor in the high incidence of severe hyperbilirubinemia in
Indonesia.
Introduction
Increased bilirubin levels are commonly seen in newborn infants and it is one of the leading
causes for hospitalization during the first week after birth [1–7]. Early diagnosis of
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hyperbilirubinemia and phototherapy treatment can prevent brain damage, while late diagno-
sis and inappropriate or ineffective treatment may account for the disproportionately high
incidence of bilirubin-induced acute encephalopathy and long-term morbidity seen in low
and middle-income countries [4]. Worldwide, an estimated 481,000 term infants suffer from
severe hyperbilirubinemia annually [5]. At least 75% of these infants live in South East Asia,
China, and sub-Saharan Africa [5,6]. A recent survey in Indonesia indicated that the incidence
of severe hyperbilirubinemia, defined as a total serum bilirubin of more than 340 μmol/L (20
mg/dL), is 7%. Acute bilirubin encephalopathy was found in 2% of the infants [7].
In Indonesia, the care of term-born infants during the first week after birth is provided pri-
marily by midwives and general practitioners (GPs). The majority of infants are not born in a
hospital, but in an obstetric clinic or at home. Several guidelines for diagnosing and treating
hyperbilirubinemia are available in Indonesia. The Indonesian Ministry of Health (IHM)
issued a guideline for midwives [8]. GPs often use the guideline issued by the World Health
Organization (WHO) [9]. The Indonesian Pediatric Society advises its members to adhere to
the guideline issued by the American Academy of Pediatrics (AAP) [10]. A part of the AAP
guideline was translated into Bahasa Indonesia, the official language of Indonesia, and issued
by the Indonesian Pediatric Collegium, the Board responsible for the education of pediatri-
cians in Indonesia [10]. In addition to issuing the guidelines, phototherapy for hyperbilirubi-
nemia was made available in almost the whole of Indonesia. Nevertheless, cases of severe
hyperbilirubinemia are still frequently seen. We wondered whether this may be related to
health professionals being unaware of the existence of these guidelines or to their failure to
adhere to the recommendations contained in them.
With the help of a questionnaire, we investigated awareness of the guidelines in three
groups of health professionals involved in the care of newborn infants: midwives, GPs, and
pediatricians. We also assessed whether these health professionals adhered to the guidelines in
daily practice.
Methods
The study was approved by the Ethical Committee in Health Research of the Dr. Soetomo
General Hospital Surabaya (number 390/ Panke.KKE/V/2017). The committee waived the
need to ask consent, because data were obtained anonymously by questionnaires. In 2016 we
handed out a questionnaire to midwives, GPs, and pediatricians at the end of a postgraduate
teaching symposium, not related to hyperbilirubinemia, held by the Indonesian Pediatric
Society (PIT IKA VIII Makassar) on East Java, Indonesia. We performed a pilot study by first
handing out the questionnaires to 25 midwives, 25 GPs, and 25 pediatricians to check the clar-
ity of the questions, variability, and reliability. The questionnaires for the three groups were
identical as far the questions on hyperbilirubinemia were concerned. Only the question relat-
ing to the professionals’ place of practice was different, as midwifes do not work in NICUs.
The questionnaire consisted of ten questions. First, we collected demographic background
information on the respondents regarding age, number of years of practice, and the number of
infants seen per month. This was followed by questions about the professionals’ awareness of
guidelines on diagnosing and treating hyperbilirubinemia and if so, whether they adhered to
the guidelines in practice. For each question the respondents could choose one of the three to
five optional answers provided. Only one answer was allowed except in the case of Question 4
(S1 Table). Finally, a clinical case was presented: a 30-year-old mother, with blood group O+,
gave birth to a 2.8 kg male infant with cephalic hematoma after 37 weeks of gestation. Before
discharge, at 36 hours after birth, the infant appeared jaundiced. I would . . . (choose the one
answer that best fits your usual practice) (S1 Table).
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Statistics
We present all the data as numbers and percentages. Using IBM SPSS Statistics, Version 21
(Chicago, IL, USA), we tested the differences for all the variables between the groups of health
professionals for significance with Pearson’s chi-square tests. Probability values of P< 0.05
were considered statistically significant.
Results
The questionnaires were handed out to 384 midwives, 250 GPs, and 593 pediatricians. The
response rates were 303 (79%), 220 (88%), and 178 (30%), resepectively. Of these question-
naires a total of 651 (53%) were filled in completely: 291 by the midwives, 206 by the GPs, and
154 by the pediatricians. We used these questionnaires for further analysis.
Table 1 provides the demographic characteristics of the respondents. The midwives were
either employed by obstetric clinics or private practices and they attended deliveries at home.
GPs saw newborn infants at their practices, while pediatricians worked in obstetric clinics,
hospitals, or in private practices. The midwives and GPs tended to be younger, had fewer
years’ experience, and saw significantly fewer infants per month compared to the pediatricians
(P< 0.05 in all three cases).
The AAP guideline was adhered to by 84% of the pediatricians, the WHO guideline by 46%
of the GPs, and 54% of the midwives adhered to the IHM guideline (Table 2). Twenty nine
percent of the midwives and 23% of the GPs were unaware of a hyperbilirubinemia guideline
or they failed to adhere to one. Almost 50% of the pediatricians indicated that they had diffi-
culty gaining access to the guidelines. Only 54% of the midwives named warning signs for
severe hyperbilirubinemia correctly (i.e. jaundice less than 24 hours after birth and jaundice to
Table 1. Demographic characteristics of the respondents.
Midwives GPs Pediatricians P value
N = 291 N = 206 N = 154
Age of the respondent (y)  30 169 (58) 116 (56) 0 (0) 0.01
31–39 65 (22) 69 (34) 56 (36)
40–49 48 (17) 17 (7) 53 (35)
50–59 8 (3) 2 (1) 33 (21)
 60 1 (0) 5 (2) 12 (8)
Years of practice  1 39 (13) 25 (12) 9 (6) 0.01
2–5 117 (40) 113 (55) 52 (34)
6–9 60 (21) 46 (22) 39 (25)
 10 75 (26) 22 (11) 54 (35)
Level of practice Nursery 113 (39) 14 (7) 77 (50) 0.01
NICU Level II 0 (0) 10 (5) 47 (30)
NICU Level III 0 (0) 8 (4) 12 (8)
Private Practice 178 (61) 174 (84) 18 (12)
Number of infants treated every month  1 19 (6) 93 (45) 0 (0) 0.01
2–5 133 (46) 71 (35) 10 (6)
6–9 46 (16) 25 (12) 12 (8)
 10 93 (32) 17 (8) 132 (86)
Data are presented as numbers and (percentages).
 P values are the results of Pearson’s chi-square tests between the groups of respondents for the categories of the demographic variables.
https://doi.org/10.1371/journal.pone.0196076.t001
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the palms of the hands and the soles of the feet) compared to 68% of the GPs and 89% of the
pediatricians (P< 0.05).
The majority of the midwives (90%) and GPs (95%) discharged the infants less than 48
hours after birth, while approximately two-thirds of the pediatricians (64%) discharged infants
more than 48 hours after birth (P< 0.05). Twenty-nine percent of the midwives and 31% of
the GPs indicated that the first follow-up visit was only after 72 hours, while infants were dis-
charged rather soon after birth. Fifty-three percent of the respondents who had indicated that
they discharged infants within 24 hours after birth scheduled the first follow-up visit after
more than 48 hours, while 22% did so after more than 72 hours (Table 3).
Table 2. Results of the survey.
Midwives GPs Pediatricians  P value
N = 291 N = 206 N = 154
Early recognition of jaundice To palms and soles









Between 24 h to 14 d










Predischarge bilirubin measurement Yes, mostly 48 (17) 53 (26) 12 (8) 0.01
Yes, if jaundice present 147 (50) 112 (54) 100 (65)
No 96 (33) 41 (20) 42 (27)
Specific guideline used IHM guideline 156 (54) 55 (27) 10 (7) 0.01
WHO guideline 41 (14) 94 (46) 7 (4)
AAP guideline 3 (1) 7 (3) 129 (84)
NICE guideline 0 (0) 2 (1) 3 (2)
No guideline 84 (29) 48 (23) 0
Other 7 (2) 0 (0) 5 (3)
Guideline access Yes 205 (71) 142 (69) 80 (52) 0.01
Not easy 85 (29) 64 (31) 74 (48)
Problems in management Education 112 (38) 22 (11) 49 (32) 0.01
Diagnostics 15 (5) 44 (21) 32 (21)
Therapy 113 (39) 97 (47) 38 (24)
Facilities 51 (18) 43 (21) 35 (23)
Case scenario Discharge and follow- up 18 (6) 19 (9) 7 (4) 0.01
Lab. tests bilirubin + BG 128 (44) 117 (57) 83 (54)
Cancel discharge and start phototherapy 25 (9) 21 (10) 62 (40)
Refer to pediatrician 120 (41) 49 (24) 2 (1)
Discharge (LOS)  24 h 163 (56) 85 (41) 11 (7) 0.01
25–48 h 99 (34) 111 (54) 45 (29)
> 48 h 29 (10) 10 (5) 98 (64)
First follow-up  24 h 14 (5) 10 (5) 0 (0) 0.01
25–48 h 107 (36) 49 (24) 9 (6)
49–72 h 87 (30) 83 (40) 66 (43)
>72 h 83 (29) 64 (31) 79 (51)
Data are numbers and (percentages).
 P values are the results of Pearson’s chi-square tests between the three types of health professionals in all categories of the variables.
Abbreviations: IHM—Indonesian Health Ministry, WHO -World Health Organization, AAP -American Academy of Pediatrics, NICE—National Institute for Health
and Care Excellence, BG—blood group, rhesus and Coombs testing, LOS—length of stay.
https://doi.org/10.1371/journal.pone.0196076.t002
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Discussion
In this questionnaire study we found that 29% of the midwives and 23% of the GPs in our sam-
ple were unaware of the existence of any guidelines to diagnose and treat hyperbilirubinemia
in newborn infants. Moreover, 46% of the midwives and 32% of the GPs did not recognize the
warning signs of clinically relevant hyperbilirubinemia correctly. Finally, almost 60% of the
midwives and more than 70% of the GPs scheduled a follow-up visit more than 48 hours after
early discharge, while the guidelines recommended seeing the infants again at least within 48
hours. These factors may contribute to the higher incidence of severe hyperbilirubinemia
found in Indonesia compared to high-income countries.
A number of studies found that severe hyperbilirubinemia is more frequent in low and
middle-income countries [4,5,11]. This may be caused either by limited availability of photo-
therapy or to late diagnosis of hyperbilirubinemia. In Indonesia, phototherapy is available in
most parts of the country, although it is uncertain whether the intensity of phototherapy is suf-
ficient everywhere. Hyperbilirubinemia is usually diagnosed by clinical assessment of the
infant, for instance, by using the Kramer jaundice score [12]. Maisels and colleagues reported
that this score can help to identify infants with increased bilirubin levels, but it is not helpful in
estimating the levels of bilirubin [13]. A bilirubin measurement, either transcutaneous or in
blood, is necessary to identify the infants who need treatment. During the first days after birth,
daily visits by health care workers are needed to detect the infants at risk of severe hyperbiliru-
binemia and whose bilirubin levels need to be checked.
Previous studies in high-income countries also found that guidelines to prevent, diagnose,
and treat hyperbilirubinemia are not always adhered to [14–17]. Tartaglia and colleagues [15]
used a compliance score to measure adherence to the AAP guideline in the Children’s Hospital
in Columbus, Ohio, USA. The compliance score increased from 60% before to 90% after an
intervention. The campaign aimed at increasing the awareness of the guidelines. Atkinson and
colleagues [14] found that pediatricians only provided phototherapy to 54% of the infants who
should have received it in accordance with the AAP guidelines. Darling and colleagues [16]
investigated the implementation of new guidelines drawn up by the Canadian Pediatric Society
in hundred Canadian hospitals. Seventy-nine hospitals indicated that they had implemented
the guidelines. Nevertheless, despite it being recommended in the guideline, only 70% of the
hospitals implemented measuring bilirubin levels before discharge. Sgro and colleagues [17]
demonstrated that introducing guidelines does indeed help to reduce the incidence of severe
hyperbilirubinemia. They found that after the Canadian guidelines were introduced the inci-
dence of severe hyperbilirubinemia decreased from 1 in 2480 to 1 in 8352 live-births.
Table 3. Timing of first follow-up visit related to discharge (length of stay).







 24 h 17 (7) 7 (3) 0 (0) 0.01
25–48 h 105 (40) 43 (17) 17 (12) 0.01
49–72 h 81 (31) 106 (41) 49 (36) 0.01
>72 h 56 (22) 99 (39) 71 (52) 0.01
Data are numbers and (percentages).
The P value is the result of the Pearson’s chi-square tests between the timing of discharge and the timing of the first
follow-up visit.
Abbreviation: LOS—length of stay.
https://doi.org/10.1371/journal.pone.0196076.t003
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There are a number of reasons why guidelines may go unheeded or why they are not
adhered to. Cabana and colleagues [18] identified the following barriers that prevent health
care professionals from adhering to clinical practice guidelines: lack of awareness, lack of
familiarity, lack of agreement, lack of self-efficacy, lack of outcome expectancy, lack of motiva-
tion to change current practice, and external barriers that affect the ability to put a recommen-
dation into practice. Most of these barriers apply to the situation in Indonesia. We found that
29% of the midwives and 23% of the GPs were unaware of the guidelines. This is a serious
problem because these health care workers take care of the majority of the millions of infants
born in Indonesia every year. Lack of agreement, lack of self-efficacy, and lack of outcome
expectancy may well play a role in the case of Indonesian midwives and GPs. Midwives advo-
cate exclusive breastfeeding, without supplementing it with formula. At the same time, breast-
feeding is an important risk factor for the development of hyperbilirubinemia, particularly if
nursing is not going well. Midwives may not be fully aware of the risks of severe hyperbilirubi-
nemia because they do not follow the infants for any length of time (only the first week) and
have limited experience as expressed by the number of newborn infant cared for. Insufficient
training may also play a role. The same risk factors may apply to GPs. One third of the pedia-
tricians indicated not to measure the bilirubin level before discharge, even though it is recom-
mended in the original AAP guideline and repeated in a recent review [3]. Such lack of
adherence may be due either to disagreement with the recommendation or the lack of motiva-
tion to change current practice. It is unlikely to be related to external barriers. Pediatricians
seem to rely on their clinical judgment, while it is known that clinical evaluation cannot reli-
ably distinguish between bilirubin levels that need treatment versus levels that do not require
treatment [3,10].
There are a number of well-known risk factors for developing severe hyperbilirubinemia in
late preterm and term infants: a gestational age of less than 38 weeks, exclusive breastfeeding,
jaundice during the first 24 hours, a previous sibling or siblings with jaundice, cephalohema-
toma or significant bruising, and hemolytic diseases [3,10,11]. Being born to an Asian mother
is also a known risk factor. The lack of knowledge regarding risk factors that we found
amongst a high percentage of midwives may also contribute to the high incidence of severe
hyperbilirubinemia in Indonesia. These factors are of special interest when newborn infants
are discharged within 48 hours after birth. A home visit by an experienced health professional
within 24 hours is recommended in case of risk factors [19].
It is tempting to speculate that the existence of different guidelines might be part of the
identified problems. The incidence of hyperbilirubinemia might be reduced if a single, uni-
form guideline were to be introduced that applies to the whole of Indonesia, and that is
adhered to by all Indonesian midwives, GPs and pediatricians. An added benefit of a nation-
wide guideline would be that whenever health care professionals move to a different part of the
country, they nevertheless continue to use the same guideline instead of having to learn to use
a different one. We plead for a guideline that addresses not only the pathophysiology of hyper-
bilirubinemia and its neurological sequelae, but also one that streamlines the way health care
for newborns is organized in Indonesia. In our opinion, uncritically adopting the guidelines
used in high-income countries is not appropriate, because Indonesian demographics are
unique and access to its health care system is organized differently.
Our study has a number of limitations. First, inspired by the study of Mateo and colleagues
[20] and because other validated questionnaires were not available, we developed and used our
own, non-validated questionnaires. We did, however, first evaluate the questions and con-
firmed that they were clear and could be answered consistently. A second limitation is that
our survey was limited to health professionals in one area of Indonesia, thus we cannot be
sure that our results apply to Indonesia as a whole. The midwives, GPs, and pediatricians who
Adherence to hyperbilirubinemia guidelines
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responded to our questionnaires comprised a relatively small proportion of the neonatal health
care workers in our area. We doubt, however, whether covering a larger area or a larger group
of participants would have changed the outcome of our survey. Finally, we did not determine
whether the health professionals in fact practiced what they had indicated in the questionnaires
and we did not check medical records.
Conclusion
Awareness of and adherence to guidelines for preventing and treating hyperbilirubinemia is
relatively low in midwives and GPs in Indonesia and needs to be addressed. We assume that
lack of awareness and lack of adherence play an important role in the high incidence of severe
hyperbilirubinemia in Indonesia. We recommend introducing a single, nation-wide guideline
to be used by all health care professionals in Indonesia who care for newborn infants in order
to reduce the incidence of hyperbilirubinemia in Indonesia.
Supporting information
S1 Table. Questionnaire on neonatal hyperbilirubinemia management on East Java, Indo-
nesia (Translated from Bahasa Indonesia to English).
(DOCX)
Acknowledgments
We would like to thank Prof. Dr. I. Dewa Gde Ugrasena for his support in conducting this
study and the residents in pediatrics of our hospital for their help in collecting the data. We
acknowledge the help of Titia van Wulfften Palthe, PhD, for editing the English manuscript.
Author Contributions
Project administration: Kinanti A. Ratnasari.
Supervision: Risa Etika, Arend F. Bos, Pieter J. J. Sauer.
Writing – original draft: Mahendra T. A. Sampurna, Kinanti A. Ratnasari, Risa Etika, Chris-
tian V. Hulzebos, Peter H. Dijk, Arend F. Bos, Pieter J. J. Sauer.
Writing – review & editing: Christian V. Hulzebos, Peter H. Dijk.
References
1. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-
assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term
infants. Pediatrics. 2008; 121(1):e170–9. https://doi.org/10.1542/peds.2006-3499 PMID: 18166536
2. Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, et al. Predischarge
screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr.
2013; 162(3):477–482.e1. https://doi.org/10.1016/j.jpeds.2012.08.022 PMID: 23043681
3. Maisels MJ: Managing the jaundiced newborn. A persistent challenge. CMAJ. 2015; 187(5):335–43.
https://doi.org/10.1503/cmaj.122117 PMID: 25384650
4. Olusanya BO, Ogunlesi TA, Kumar P, Boo N-Y, Iskander IF, de Almeida MFB, et al. Management of
late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings. BMC Pediatr.
2015; 15:39–51. https://doi.org/10.1186/s12887-015-0358-z PMID: 25884679
5. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al. Neonatal hyperbilirubinemia
and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and
global levels. Pediatr Res. 2013; 74:86–100. https://doi.org/10.1038/pr.2013.208 PMID: 24366465
Adherence to hyperbilirubinemia guidelines
PLOS ONE | https://doi.org/10.1371/journal.pone.0196076 April 19, 2018 7 / 8
6. Yu C, Li H, Zhang Q, He H, Chen X, Hua Z. Report about term infants with severe hyperbilirubinemia
undergoing exchange transfusion in Southwestern China during 11 -year period, from 2001 to 2011.
PLoS ONE. 2017; 12(6):e0179550. https://doi.org/10.1371/journal.pone.0179550 PMID: 28662083
7. Greco C, Arnolda G, Boo NY, Iskander IF, Okolo AA, Rohsiswatmo R, et al. Neonatal Jaundice in Low-
and Middle-Income Countries: Lessons and Future Directions from the 2015 Don Ostrow Trieste Yellow
Retreat. Neonatology. 2016; 110(3):172–80. https://doi.org/10.1159/000445708 PMID: 27172942
8. Kementerian Kesehatan RI: Buku Saku Pelayanan Kesehatan Neonatal Esensial. 2010;xviii. http://
www.gizikia.depkes.go.id/wp-content/uploads/downloads/2011/09/Buku-Saku-Pelayanan-Kesehatan-
Neonatal-Esensial.pdf. Visited on November 12th 2016.
9. World Health Organization. Other common neonatal problems: Jaundice; in WHO: Pocketbook of Hos-
pital care for children: guidelines for the management of common childhood illnesses, Second edition.
Geneva, Switerland, WHO, 2013, pp 64–65.
10. Dewi R, Dewanto NEF. Hyperbilirubinemia. In Pedoman Pelayanan Medis Ikatan Dokter Anak Indone-
sia Second Edition. Pudjiadi AH, Hegar B, Handryastuti S, Idris NS, Gandaputra EP, Harmoniati ED,
et al. Eds. Badan Penerbit Ikatan Dokter Anak Indonesia. Jakarta, 2011. p. 114.
11. Olusanya BO, Osibanjo FB, Slusher TM. Risk Factors for Severe Neonatal Hyperbilirubinemia in Low
and Middle-Income Countries: A Systematic Review and Meta-Analysis. PLoS ONE. 2015; 10(2):
e0117229. https://doi.10.1371/journal.pone.0117229 PMID: 25675342
12. Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child. 1969; 118
(3):454–8. PMID: 5817480
13. Maisels MJ, Clune S, Coleman K, Gendelman B, Kendall A, McManus S, et al. The natural history of
jaundice in predominantly breastfed infants. Pediatrics 2014; 134(2):e340–5. https://doi.org/10.1542/
peds.2013-4299 PMID: 25049352
14. Atkinson LR, Escobar GJ, Takayama JI, Newman TB. Phototherapy use in jaundiced newborns in a
large managed care organization: do clinicians adhere to the guideline? Pediatrics. 2003; 111(5 Pt 1):
e555–61. PMID: 12728109
15. Tartaglia M, Campbell J, Shaniuk P, Mcclead E. QUALITY REPORT A Quality Project to Improve Com-
pliance With AAP Guidelines for Inpatient Management of Neonatal Hyperbilirubinemia. Hosp Pediatr.
2015; 3(3):251–7.
16. Darling EK, Guttmann A, Sprague AE, Ramsay T, Walker MC. Implementation of the Canadian Paedi-
atric Society’s hyperbilirubinemia guidelines: A survey of Ontario hospitals. Paediatr Child Health. 2014;
19(3):133–7. PMID: 24665223
17. Sgro M, Kandasamy S, Shah V, Ofner M, Campbell D. Severe neonatal hyperbilirubinemia decreased
after the 2007 Canadian guidelines. J Pediatr. 2016; 171:43–7. https://doi.org/10.1016/j.jpeds.2015.12.
067 PMID: 26852177
18. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don’t physicians follow
clinical practice guidelines? A framework for improvement. JAMA. 1999; 282(15):1458–65. PMID:
10535437
19. Lain SJ, Roberts CL, Bowen JR, Nassar N. Early discharge of infants and risk of readmission for jaun-
dice. Pediatr. 2015; 135(2):314–21.
20. Mateo PC, Lee KS, Barozzino M, Sgro M. Management of neonatal jaundice varies by practitioner type.
Canadian Family Physician. 2013; 59:e379–86. PMID: 23946045
Adherence to hyperbilirubinemia guidelines
PLOS ONE | https://doi.org/10.1371/journal.pone.0196076 April 19, 2018 8 / 8
